Cell-based Delivery of Oncolytic Viruses: A New Strategic Alliance for a Biological Strike Against Cancer
Open Access
- 1 April 2007
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (4), 660-665
- https://doi.org/10.1038/sj.mt.6300098
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Carrier Cell-based Delivery of an Oncolytic Virus Circumvents Antiviral ImmunityMolecular Therapy, 2007
- Infected Cell Carriers: A New Strategy for Systemic Delivery of Oncolytic Measles Viruses in Cancer VirotherapyMolecular Therapy, 2007
- Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSFMolecular Therapy, 2006
- Adenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic DeliveryMolecular Therapy, 2006
- The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinomaMolecular Therapy, 2005
- Rescue and propagation of fully retargeted oncolytic measles virusesNature Biotechnology, 2005
- Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell markerBlood, 2003
- Dissemination and growth of cancer cells in metastatic sitesNature Reviews Cancer, 2002
- Brief Report: Liver Bypass Significantly Increases the Transduction Efficiency of Recombinant Adenoviral Vectors in the Lung, Intestine, and KidneyHuman Gene Therapy, 2000
- Origins of circulating endothelial cells and endothelial outgrowth from bloodJournal of Clinical Investigation, 2000